Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

New research suggests that drugs like Ozempic may provide more health benefits than previously thought. These medications, ...

Experts explain if Ozempic causes hair loss, and how the medication may indirectly lead to weight loss-related hair loss due ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

High-protein diets boost weight loss, but too much can backfire. Why excess protein might be slowing your fat loss and how to ...

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...